In a major hope to battle the global pandemic, India has now granted approval to Covishield, Serum Institute of India’s vaccine candidate, as per sources. Gearing up for to begin the process of immunisation, a high-level meeting was also convened today today. Post which, it was announced that a dry vaccine drive that will be starting tomorrow, January 2. UK has already given its nod to the AstraZeneca vaccine for emergency use.
CoWIN is a digitalised platform that will be used to effectively roll out and scale up the mechanism for Covid-19 Vaccine Distribution System, nationally. Healthcare workers, Frontline workers, and People above 50-year can register on CoWIN. COVID-19 Vaccine Intelligence Network aims to facilitate the vaccination process but is yet to be released. There will be a compulsory Registration and CoWIN will communicate the date, time & slot for vaccination and also monitor side-effects & unusual symptoms.
#BreakingNews | Serum Institute of India's vaccine candidate, Covishield approved for emergency use in India: Sources pic.twitter.com/otkBMFOiky
— NewsX (@NewsX) January 1, 2021
Also Read: Mission 2021: Steps and Plans to Revive India’s Economy & Businesses
Also Read: Amid border tensions with China, Plans for India’s Mission 2021 on borders
Target of this exercise is that minutest details are thoroughly researched. At least 2 vaccines have sent their applications to Drug Controller & experts for approval, their data are being studied pro-actively:Union Health Min Dr Harsh Vardhan on Covid-19 vaccine dry run on Jan 2 https://t.co/f1dy2CtfNj
— ANI (@ANI) January 1, 2021
After training over 2,000 master trainers at the national level, the training is underway at State and district level, in over 700 districts. The procedure is similar to conducting elections where the team at a booth is also trained: Union Health Minister Dr Harsh Vardhan https://t.co/P4ti88kUEN
— ANI (@ANI) January 1, 2021